A Plus Biotechnology Co (TPE:6918) Total Operating Expense: NT$364.7 Mil (TTM As of Dec. 2025)


TPE:6918 A Plus Biotechnology Co Ltd TPE:6918
72 GF Score
Price NT$74.10
GF Value NT$87.17
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is A Plus Biotechnology Co Total Operating Expense?

A Plus Biotechnology Co TPE:6918 -0.13% 72 Total Operating Expense is NT$364.7 Mil as of Dec. 2025. GuruFocus rates TPE:6918 with a GF Score™ of 72/100 and a GF Value™ of NT$87.17 (Modestly Undervalued). The stock has 3 warning signs investors should review.

A Plus Biotechnology Co's Total Operating Expense for the three months ended in Dec. 2025 was NT$91.5 Mil. A Plus Biotechnology Co's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$364.7 Mil.

A Plus Biotechnology Co Total Operating Expense Related Terms

A Plus Biotechnology Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for A Plus Biotechnology Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A Plus Biotechnology Co Total Operating Expense Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 300.24 304.93 292.97 352.50 364.70

A Plus Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.14 87.51 89.96 95.69 91.54
TPE:6918
72GF Score
A Plus Biotechnology Co Ltd TPE:6918
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

A Plus Biotechnology Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$364.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of NT$364.7 Mil mean?
A Plus Biotechnology Co (TPE:6918) has a Total Operating Expense of NT$364.7 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on A Plus Biotechnology Co and its competitors.
Is A Plus Biotechnology Co's Total Operating Expense too high?
A Plus Biotechnology Co's current Total Operating Expense is NT$364.7 Mil. Overall, A Plus Biotechnology Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does A Plus Biotechnology Co's Total Operating Expense compare to ABT and SYK?
A Plus Biotechnology Co's Total Operating Expense of NT$364.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on A Plus Biotechnology Co and its competitors. A Plus Biotechnology Co's current Total Operating Expense is NT$364.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is A Plus Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, A Plus Biotechnology Co (TPE:6918) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.17, compared to a current price of NT$74.10 — trading 15% below its estimated fair value. The current Total Operating Expense is NT$364.7 Mil. A Plus Biotechnology Co's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For A Plus Biotechnology Co (TPE:6918), the current Total Operating Expense is NT$364.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is A Plus Biotechnology Co (TPE:6918) Overvalued in 2026?

Based on GuruFocus' analysis, A Plus Biotechnology Co stock appears to be undervalued. The current stock price of NT$74.10 is trading 15% below its estimated GF Value™ of NT$87.17. GuruFocus considers A Plus Biotechnology Co to be Modestly Undervalued.

Key valuation signals for TPE:6918:

  • Total Operating Expense: NT$364.7 Mil
  • GF Value™: NT$87.17 vs. price of NT$74.10 (15% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the TPE:6918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

A Plus Biotechnology Co Business Description

Address No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
A Plus Biotechnology Co Ltd provides orthopedic implants and engages in the manufacturing and wholesale of medical devices such as bone material. The company's products include Chest, Shoulder, Spine, Elbow, Wrist & Hand, Pelvic & Hip, Knee, Foot & Ankle, Osteotomy, Pediatric & ESF, and Biologics. The company currently has operating segments in Taiwan and China, with the majority of revenue coming from Taiwan.
72GF Score

Get the complete analysis for TPE:6918

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$74.10
Price
NT$87.17
GF Value